Indeed, PPARγ-deficient mice develop more severe MCD-induced NAFLD, whereas adenovirus-mediated PPARγ overexpression attenuated the progression of NASH [55]. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatohepatitis.